(Q40590316)

21 September 2017

title

The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients (English)

1 reference

21 September 2017

1 reference

5

Earl Bogoch

1 reference

21 September 2017

Gillian Hawker

1

1 reference

21 September 2017

Rowena Ridout

series ordinal

2

1 reference

21 September 2017

Maria Ricupero

series ordinal

3

1 reference

21 September 2017

Susan Jaglal

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

4 March 2003

1 reference

Osteoporosis International

21 September 2017

published in

1 reference

21 September 2017

volume

14

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

171-178

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-003-1377-4

21 September 2017

exact match

0 references

cites work

Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

The crippling consequences of fractures and their impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

How well are community-living women treated for osteoporosis after hip fracture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Osteoporosis intervention following distal forearm fractures: a missed opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Questionnaire survey of advice given to patients with fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Prescribing by general practitioners after an osteoporotic fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Use of bone densitometry by Ontario family physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Risk of Mortality Following Clinical Fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-003-1377-4

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

21 January 2018

1 reference

12 December 2020

Osteoporosis follow-up after wrist fractures following minor trauma

1 reference

12 December 2020

Medical costs of osteoporosis

1 reference

12 December 2020

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

12 December 2020

Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures.

1 reference

12 December 2020

How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs

1 reference

12 December 2020

Investigation and treatment of osteoporosis in patients with fragility fractures.

1 reference

12 December 2020

Functional recovery after fracture of the hip.

1 reference

12 December 2020

10.1007/S00198-003-1377-4

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1047388115

0 references

1 reference